Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely formulated TPD strategies. In this evaluate, we give attention to the two preclinical experiments and clinical trials to offer an extensive summary of the safety and medical usefulness of PROTACs and MGDs in hematologic malignancies over the https://frankj318chl2.nytechwiki.com/user